Dr. Anil Handoo

Dr. Anil Handoo

Laboratory Services, Haematology

21+

MBBS, MD, Fellowship

BLK Max Super Speciality Hospital, Delhi – India BLK Max Super Speciality Hospital, Delhi – India

ChatYou are Viewing our Top Doctor

ChatChat on WhatsApp

About Dr. Anil Handoo

Dr. Anil Handoo is a pre-eminent figure in laboratory medicine in India. With over two decades of experience, he is a foremost expert in diagnostic haematology, steering the crucial laboratory investigations that underpin accurate cancer diagnosis and treatment. His expertise in flow cytometry and molecular haematology is pivotal for identifying and classifying leukaemia, lymphoma, and other blood malignancies. Dr. Handoo holds prestigious international fellowships from London and Australia and is a technical assessor for NABL, setting the benchmark for quality and precision in haematological diagnostics across the country.

Medical Degrees
  • MBBS: Manipal Academy of Higher Education, Manipal, India
  • MD (Pathology): Manipal Academy of Higher Education, Manipal, India
Fellowships & Special Training
  • Fellowship in Hematological Medicine: London, UK
  • Fellowship in Flow Cytometry: Australia
Certifications & Accreditations
  • Technical Assessor for NABL (National Accreditation Board for Testing and Calibration Laboratories) in Hematology, Molecular Hematology, and Flow Cytometry.

As a specialist in Laboratory Medicine, Dr. Handoo provides the critical diagnostic support required for treating a wide range of cancers and blood disorders. He provides the expert analysis that guides clinical haematologists and oncologists.
  • Diagnostic Specialities:
    • Neoplastic Flow Cytometry: For the diagnosis, classification, and monitoring of leukaemia and lymphoma.
    • Molecular Haematology: Detecting genetic mutations in blood cancers for targeted therapy and prognosis.
    • HLA (Human Leukocyte Antigen) Typing: Essential for determining donor compatibility for bone marrow transplants.
    • Haemostasis: Diagnosis of complex bleeding and clotting disorders.
  • Advanced Diagnostic Techniques:
    • Multi-parametric Flow Cytometry for blood and bone marrow analysis.
    • Advanced Molecular Assays for haematological malignancies.
    • Comprehensive coagulation testing.
    • Cytomorphology of lymph nodes and bone marrow.

Current & Past Hospital Affiliations
  • Principal Director - Laboratory Services: Max Healthcare, New Delhi (Present)
  • Senior Director - Laboratory Services: BLK-Max Super Speciality Hospital, New Delhi
  • Consultant & In-charge Haematology: Medanta - The Medicity, Gurugram
  • Consultant Hematologist: Sir Ganga Ram Hospital, New Delhi
Academic & Research Roles
  • Technical Assessor for NABL: A key role in upholding laboratory standards across India.
  • Serves as an expert on various national and international committees for haematology and flow cytometry.
  • Faculty for flow cytometry training for academic institutions and industry partners.
Key Achievements & Contributions
  • A leading authority in establishing and directing high-quality, accredited haematology laboratories in major Indian hospitals.
  • Instrumental in advancing the use of multi-parametric flow cytometry as a rapid and reliable diagnostic tool in India.
  • Published extensive research on innovative applications of flow cytometry and diagnostic haematology.

Academic Awards
  • Distinction in 1st, 2nd, and Final MBBS Professional Examinations.
  • Distinction in multiple subjects including Anatomy, Physiology, Biochemistry, Medicine, and Paediatrics.
Recognitions & Honors
  • Life Member of the Indian Society of Hematology and Transfusion Medicine (ISHBT).
  • Member of the International Clinical Cytometry Society.
  • Life Member of The Cytometry Society (India).
  • Life Member of the Indian Association of Pathologists & Microbiologists.

Published Papers in Medical Journals
  • CD45-side scatter dot plot in malignant hematological flow cytometry... - International Journal of Laboratory Hematology (2012)
  • Multi-Parametric Lymph Node Flow Cytometry With Cytomorphology... - International Journal of Laboratory Hematology (2012)
  • Case report of HbC/β°-thalassemia from India. - International Journal of Laboratory Hematology (2007)
  • Sarcomatoid Renal cell Carcinoma with Osteosarcomatous differentiation... - Indian Journal of Pathology and Microbiology (2004)
  • Urethral obstruction due to lobular mesonephric hyperplasia of the vagina... - Indian Journal of Pathology and Microbiology (2005)

As a laboratory specialist, Dr. Handoo does not have direct patient testimonials. However, his work is praised by clinical colleagues.
  • "Dr. Handoo\'s diagnostic reports are the bedrock of our BMT program. His precision in HLA typing and minimal residual disease (MRD) analysis through flow cytometry is unparalleled. We can proceed with complex transplants with full confidence in his findings."
  • "The speed and accuracy of Dr. Handoo’s lab are critical in acute leukaemia cases. His ability to provide a definitive diagnosis within hours using flow cytometry directly translates to better patient outcomes. He is an invaluable asset to the oncology community."

  • Patient-Centred Care (via Diagnostics): Dr. Handoo’s philosophy is centred on providing clinicians with the most accurate, reliable, and timely diagnostic information possible. He understands that behind every sample is a patient waiting for a crucial diagnosis, and his commitment to quality directly impacts patient care and treatment strategy.
  • Technology & Innovation: He is a pioneer in adopting and standardising cutting-edge laboratory technologies in India. By championing advanced techniques like multi-parametric flow cytometry and molecular diagnostics, Dr. Handoo ensures that the diagnostic capabilities at his labs are on par with the best international standards, enabling precise and personalised medicine.

Diagnostic Test / PanelEstimated Cost (INR)Estimated Cost (USD)
Leukaemia/Lymphoma Panel (Flow Cytometry)₹ 15,000 - ₹ 25,000$ 180 - $ 300
Molecular Haematology Test (e.g., BCR-ABL)₹ 5,000 - ₹ 15,000$ 60 - $ 180
High-Resolution HLA Typing (for BMT)₹ 20,000 - ₹ 40,000$ 240 - $ 480
Minimal Residual Disease (MRD) Test₹ 18,000 - ₹ 30,000$ 215 - $ 360
Note: The above costs are estimates and can vary based on the complexity of the test. The Cancer Rounds team can provide precise cost details.

  • Language Support: The Cancer Rounds team facilitates communication and coordination for international patients, ensuring that diagnostic reports and any necessary clarifications are handled smoothly.
  • Visa & Travel Assistance: Our team can assist with the logistics for international patients requiring specialised diagnostic tests in India, helping coordinate sample transport or patient travel if needed.
  • Pre-treatment Virtual Consultations: While Dr. Handoo does not conduct patient consultations, the Cancer Rounds team can arrange virtual consultations with the treating clinical haematologist, where Dr. Handoo’s diagnostic findings will be discussed as part of the overall treatment plan.

Frequently Asked Questions

Answer: Dr. Anil Handoo is a specialist in laboratory haematology. He does not directly treat patients but leads the laboratory team that performs critical diagnostic tests on blood, bone marrow, and tissue samples. His reports help oncologists accurately diagnose cancers like leukaemia and lymphoma, determine the best treatment, and monitor the patient's response.

Answer: Flow cytometry is a sophisticated laboratory technique used to identify and count specific types of cells. In oncology, it is essential for rapidly diagnosing and classifying blood cancers (leukaemia/lymphoma), assessing the cancer's aggressiveness, and detecting tiny amounts of remaining cancer cells after treatment (Minimal Residual Disease or MRD). Dr. Handoo is a leading expert in this technology.

Answer: Molecular haematology involves testing for specific genetic mutations or markers within cancer cells. This information is crucial for personalised medicine, as it helps doctors choose targeted therapies that are most effective against a patient's specific type of cancer.

Answer: Dr. Handoo’s laboratory plays a vital role in BMT by performing HLA (Human Leukocyte Antigen) typing. This test is critical for finding a matching bone marrow donor to minimise the risk of transplant rejection. His lab also monitors the success of the transplant post-procedure.

Answer: As a laboratory specialist, Dr. Handoo does not hold patient consultations. Your treating oncologist or haematologist will consult with him and his team to ensure the most accurate diagnosis and will discuss the results of the laboratory tests with you. You can connect with top haematologists through the Cancer Rounds team.